, Tracking Stock Market Picks
Enter Symbol:
Cardiome Pharma Corporation (CRME) [hlAlert]

down 77.66 %

Cardiome Pharma Corporation (CRME) rated Outperform by Wachovia

Posted on: Thursday,  Mar 20, 2008  8:25 AM ET by Wachovia

Wachovia rated Outperform Cardiome Pharma Corporation (NASDAQ: CRME) on 03/20/2008, when the stock price was $39.45. Since
then, Cardiome Pharma Corporation has lost 77.67% as of 08/27/2015's recent price of $8.81.
If you would have followed this Wachovia's recommendation on CRME, you would have lost 77.66% of your investment in 2716 days.

Cardiome Pharma Corp. is a product-focused cardiovascular drug development company with two clinical drug programs focused on atrial arrhythmia (intravenous and oral dosing), and a pre-clinical program directed at improving cardiovascular function.

Wachovia offers a full range of products and services to meet the needs of corporate and institutional clients nationwide. These include capital raising, market making, and financial advisory products and services, to name just a few. We have the experience and resources you need to help your business grow and succeed. With a unified culture and integrated platform, ours is an organization that executes without distraction. We are focused and proactive, working as a team to deliver the ideas and capital for your needs.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/20/2008 8:25 AM Buy
as of 12/24/2008
1 Week down  -8.23 %
1 Month up  11.11 %
3 Months down  -19.75 %
1 YTD down  -14.28 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy